The role of cardiopulmonary exercise test in the differential diagnosis of dyspnea in patient with primary pulmonary arterial hypertension
DOI:
https://doi.org/10.33448/rsd-v12i6.41833Keywords:
Cardiopulmonary exercise test; Pulmonary arterial hypertension; Systemic sclerosis.Abstract
Introduction: Pulmonary arterial hypertension (PAH) is hemodynamically characterized by a mean pulmonary artery pressure (mPAP) >20 mmHg at rest. Patients with Systemic Sclerosis (SS) can be affected by PAH and evolve with a reserved prognosis. The gold standard for diagnosis is right heart catheterization, but non-invasive methods allow anatomical and functional monitoring to assess severity and treatment. The Cardiopulmonary Exercise Test (CPET) assesses the aerobic condition, the possible mechanism responsible for reduced exercise capacity and prognostic markers, and its role in patients with SSc and PAH is recognized. Objective: the study aims to use the cardiopulmonary exercise test in the differential diagnosis of dyspnea in a patient with primary pulmonary hypertension. Methodology: This is a case report associated with a literature review. Conclusion: In the clinical case addressed, the importance of CPET in the differential diagnosis of dyspnea and in the evaluation of prognostic markers is evident, helping in the therapeutic decision, in order to provide better quality of life and survival of patients.
References
Arena, R., Guazzi, M., Myers, J., Grinnen, D., Forman, D., & Lavie, C. (2011). Cardiopulmonary exercise testing in the assessment of pulmonary hypertension. Expert review of respiratory medicine, 5(2), 281-293.
Callou, M., & Ramos, P. (2009). 16. Hipertensão arterial pulmonar. Arquivos Brasileiros de Cardiologia, 93, 156-159.
Dumitrescu, D., Nagel, C., Kovacs, G., Bollmann, T., Halank, M., Winkler, J., & Rosenkranz, S. (2017). Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis. Heart, 103(10), 774-782.
Ewert, R., Ittermann, T., Habedank, D., Held, M., Lange, T., Halank, M., & Kovacs, G. (2019). Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis. BMC pulmonary medicine, 19, 1-12.
Farina, S., Correale, M., Bruno, N., Paolillo, S., Salvioni, E., Badagliacca, R., & Agostoni, P. (2018). The role of cardiopulmonary exercise tests in pulmonary arterial hypertension. European Respiratory Review, 27(148).
Guazzi, M., Bandera, F., Ozemek, C., Systrom, D., & Arena, R. (2017). Cardiopulmonary exercise testing: what is its value?. Journal of the American College of Cardiology, 70(13), 1618-1636.
Holverda, S., Bogaard, H., Groepenhoff, H., Postmus, P., Boonstra, A., & Vonk-Noordegraaf, A. (2008). Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respiration, 76(2), 160-167.
Hsu, V., Chung, L., Hummers, L., Wigley, F., Simms, R., Bolster, M., & Steen, V. (2014, August). Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. In Seminars in Arthritis and Rheumatism (Vol. 44, No. 1, pp. 55-62). WB Saunders.
Humbert, M., Kovacs, G., Hoeper, M., Badagliacca, R., Berger, R., Brida, M., & Rosenkranz, S. (2022). 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). European heart journal, 43(38), 3618-3731.
Lewis, R., Billings, C., Hurdman, J., Smith, I., Austin, M., Armstrong, I., & Kiely, D. (2021). Maximal exercise testing using the incremental shuttle walking test can be used to risk-stratify patients with pulmonary arterial hypertension. Annals of the American Thoracic Society, 18(1), 34-43.
Luo, Q., Yu, X., Zhao, Z., Zhao, Q., Ma, X., Jin, Q., & Liu, Z. (2021). The value of cardiopulmonary exercise testing in the diagnosis of pulmonary hypertension. Journal of thoracic disease, 13(1), 178.
McGoon, M., Benza, R., Escribano, S., Jiang, X., Miller, D.., Peacock, A., & Humbert, M. (2013). Pulmonary arterial hypertension: epidemiology and registries. Journal of the American College of Cardiology, 62(25S), D51-D59.
Naeije, R., Blanco, I., & Barberà, J. (2011). Prueba de esfuerzo cardiopulmonar en el manejo del paciente con hipertensión pulmonar. Archivos de Bronconeumología, 47, 15-20.
Niklas, K., Niklas, A., Mularek, T., & Puszczewicz, M. (2018). Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease. Medicine, 97(28).
Pasarikovski, C., Granton, J.., Roos, A., Sadeghi, S., Kron, A., Thenganatt, J., & Johnson, S. (2016). Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study. Arthritis Research & Therapy, 18, 1-7.
Paolillo, S., Farina, S., Bussotti, M., Iorio, A., Filardi, P., Piepoli, M., & Agostoni, P. (2012). Exercise testing in the clinical management of patients affected by pulmonary arterial hypertension. European journal of preventive cardiology, 19(5), 960-971.
Pugh, M., Sivarajan, L., Wang, L., Robbins, I., Newman, J., & Hemnes, A. (2014). Causes of pulmonary hypertension in the elderly. Chest, 146(1), 159-166.
Robertson, C., Oates, E., Fletcher, J., & Sylvester, P. (2021). The association of six-minute walk work and other clinical measures to cardiopulmonary exercise test parameters in pulmonary vascular disease. Pulmonary Circulation, 11(4), 20458940211059055.
Rubin, L., Hopkins, W., & Nicholson, A. (2017). The epidemiology and pathogenesis of pulmonary arterial hypertension (Group 1). UpToDate. Nov, 28.
Sabbahi, A., Severin, R., Ozemek, C., Phillips, S., & Arena, R. (2020). The role of cardiopulmonary exercise testing and training in patients with pulmonary hypertension: making the case for this assessment and intervention to be considered a standard of care. Expert review of respiratory medicine, 14(3), 317-327.
Schwaiblmair, M., Faul, C., Von, S., & Berghaus, T. (2012). Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension. BMC pulmonary medicine, 12, 1-7.
Simonneau, G., Montani, D., Celermajer, D., Denton, C., Gatzoulis, M., Krowka, M., & Souza, R. (2019). Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European respiratory journal, 53(1).
Singh, I., Joseph, P., Heerdt, P., Cullinan, M., Lutchmansingh, D., Gulati, M., & Waxman, A. (2022). Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest, 161(1), 54-63.
Thirapatarapong, W., Armstrong, H., & Bartels, M. (2014). Comparing cardiopulmonary exercise testing in severe COPD patients with and without pulmonary hypertension. Heart, Lung and Circulation, 23(9), 833-840.
Weatherald, J., Farina, S., Bruno, N., & Laveneziana, P. (2017). Cardiopulmonary exercise testing in pulmonary hypertension. Annals of the American Thoracic Society, 14(Supplement 1), S84-S92.
Wensel, R., Francis, D., Meyer, F., Opitz, C., Bruch, L., Halank, M., & Ewert, R. (2013). Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension. International journal of cardiology, 167(4), 1193-1198.
Zhu, H., Sun, X., Cao, Y., Pudasaini, B., Yang, W., Liu, J., & Guo, J. (2021). Cardiopulmonary exercise testing and pulmonary function testing for predicting the severity of CTEPH. BMC Pulmonary Medicine, 21, 1-10.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Mateus Araújo dos Santos; Ana Carolina Amorim de Oliveira; Danielle Alves Barreto; Mariana Carvalho Alves; Marcell Coutinho da Silva; Milena dos Santos Barros Campos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
